Preclinical evaluation of innate immunity to baculovirus gene therapy vectors in whole human blood
- 8 August 2009
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 46 (15) , 2911-2917
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Adenovirus Type 5 Interactions with Human Blood Cells May Compromise Systemic DeliveryMolecular Therapy, 2006
- Involvement of the Toll-Like Receptor 9 Signaling Pathway in the Induction of Innate Immunity by BaculovirusJournal of Virology, 2005
- Blood coagulation factors as inflammatory mediatorsBlood Cells, Molecules, and Diseases, 2005
- Complement inhibition rescued mice allowing observation of transgene expression following intraportal delivery of baculovirus in miceThe Journal of Gene Medicine, 2004
- Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation1Transplantation, 2003
- Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transferMolecular Genetics and Metabolism, 2003
- Complement activation by recombinant adenovirusesGene Therapy, 2001
- Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectorsNature Biotechnology, 2001
- Baculovirus-mediated periadventitial gene transfer to rabbit carotid arteryGene Therapy, 2000
- Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement systemGene Therapy, 1998